NCT05416086View on ClinicalTrials.gov

iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 3, 2021

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Atrial FibrillationAtrial FlutterParoxysmal Atrial FibrillationPersistent Atrial Fibrillation
Interventions
DEVICE

cryoablation procedure using the iCLAS Cryoablation System

all subjects will receive a cryoablation procedure using the iCLAS Cryoablation System (catheter, stylets, and console) and warming balloon

Trial Locations (4)

3435

RECRUITING

St. Antonius Ziekenhuis, Nieuwegein

9300

RECRUITING

Onze-Lieve-Vrouw Hospital Aalst (OLV), Aalst

91054

RECRUITING

Universitatsklinikum Erlangen, Erlangen

Unknown

RECRUITING

Erasmus MC, Rotterdam

Sponsors

Lead Sponsor

Adagio Medical
All Listed Sponsors
lead

Adagio Medical

INDUSTRY

NCT05416086 - iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study | Biotech Hunter | Biotech Hunter